|
|
|
|
Available: Yes* |
This title does not qualify for any discount. |
|
Other formats:
|
Edition: | 1st |
Publisher: | Wiley, John & Sons, Inc. |
ISBN: | 1-118-21042-5 (1118210425) |
ISBN-13: | 978-1-118-21042-0 (9781118210420) |
Binding: | E E Book + ProQuest Ebook Central |
Copyright: | 2010 |
Publish Date: | 02/10 |
Weight: | 0.00 Lbs. |
Carton Quantity: | 12 |
Subject Class: | RET (Returns) |
Remarks: | A New Edition of this Title is Available |
Return Policy: | Non-Returnable. |
Table Of Contents: |
View
|
|
|
ProQuest Ebook Central�: |
Please sign in to preview this title
|
|
|
|
Discipline: | Pharmacology | Subject Definition: | Biomarkers, Pharmacological; Drug Design; Drug Discovery | NLM Class: | QV 744 | LC Class: | R853 | Abstract: | As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of thedrug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development. |
|
* Subject to ProQuest Ebook Central� availability |
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews